Find clinical trials for Multiple Myeloma in Nashville, TN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Nashville, TN, USA:
in 2 sequential cohorts of participants with relapsed or refractory multiple myeloma (RRMM). The primary objective of this study is...
Phase 2
Nashville, Tennessee, United States and 2 other locations
This is a phase II study to evaluate the outpatient administration of Teclistamab or Talquetamab in Multiple Myeloma patients...
Phase 2
Nashville, Tennessee, United States and 16 other locations
The purpose of this study is to evaluate the safety and preliminary efficacy of CC-92480 in combination with standard treatments.
Phase 1, Phase 2
Nashville, Tennessee, United States and 48 other locations
The purpose of this study is to evaluate the safety and tolerability of mRNA-2808 in participants with relapsed or refractory multiple myeloma...
Phase 1, Phase 2
Nashville, Tennessee, United States and 9 other locations
The purpose of this study is to assess the safety, tolerability, preliminary efficacy, cellular kinetics, and other exploratory endpoints of AZD4045...
Phase 1, Phase 2
Nashville, Tennessee, United States and 11 other locations
characterize the safety, tolerability, PK, and PD of cemsidomide in combination with dexamethasone in participants with relapsed/refractory multiple...
Phase 2
Nashville, Tennessee, United States and 20 other locations
is a Phase 1b/2, open-label, multicenter study of AZD0120, a CD19/BCMA dual CAR T-cell therapy, in adult subjects with relapsed/refractory multiple...
Phase 1, Phase 2
Nashville, Tennessee, United States and 35 other locations
This is an open-label, multi-site, Phase II randomized trial with response-adaptive design for newly diagnosed multiple myeloma (ND...
Phase 2
Nashville, Tennessee, United States and 10 other locations
The purpose of this research study is to evaluate a treatment regimen called IRD which will be given to participants after their stem cell transplant...
Phase 2
Nashville, Tennessee, United States and 9 other locations
1b/2, open label, multi-center, Clinical Study of Chimeric Antigen Receptor T Cells targeting BCMA in patients with relapsed and or refractory multiple...
Phase 1, Phase 2
Nashville, Tennessee, United States and 12 other locations
Clinical trials
Research sites
Resources
Legal